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Abstract Chinese hamster ovary (CHO) cells were transfected with the human c-fmr gene, which encodes the receptor for macrophage colony- 
stimulating factor, to examine the effects on the low density lipoprotein (LDL) receptor activity. Degradation of [‘=IJLDL was significantly reduced 
in the transfected CHO cells as compared to non-transfected cells when incubated in lipoproteindeficient serum. Quantitative analysis of LDL 
receptor mRNA using a competitive PCR method demonstrated that LDL receptor suppression occurred at transcription. These findings suggest 
that expression of the c-fm gene is involved in the regulation of LDL receptors on macrophages. 
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1. IutNnluctlon 
The c-fms proto-oncogene ncodes the macrophage colony- 
stimulating factor (M-CSF) receptor, which plays a critical role 
in the proliferation and differentiation of cells of the monocyte- 
macrophage lineage [1,2]. Binding of M-CSF to its receptors 
activates the intrinsic tyrosine kinase activity of the receptors. 
Rapid phosphorylation at tyrosine residues ensues, initiating a 
cascade of metabolic and gene regulatory events involved in cell 
growth and differentiation [3,4]. In the initial stages of athero- 
sclerosis, monocytes migrate from the circulating blood to the 
subendothelial space, where they mature and differentiate into 
macrophages and endocytose lipoprotein cholesterol through 
lipoprotein receptors [5-81. LDL receptor activity is reduced 
and scavenger eceptor activity is induced during maturation 
and differentiation of monocytes to macrophages in vitro 
[9-l 11. Since expression of c-fm generally coincides with ditfer- 
entiation to the monocyte-macrophage lineage, lipoprotein re- 
ceptor activities may be related to c-fms gene expression in 
monocytes and macrophages. However, the influences of c-fms 
expression on lipoprotein receptor activities has not been well 
studied. In the present study, we transfected the human c-fms 
gene into CHO cells to examine its effects on LDL receptor 
activity. 
2. Materials and methods 
2.1. Materials 
CHO-K cells were purchased from American Type Culture Collec- 
tion. Ham’s F-12 medium (HAM), RPM1 1640 medium, newborn calf 
serum (NCS) and fetal calf serum (FCS) were purchased from Gibco. 
Geneticine (G-418) was purchased from Sigma Chemical Co. (St. 
Louis, MO). Narz51 and [Hlthymidine were purchased from ICN Bi- 
omedicals Inc. [a-“*P]dCTP and [“‘IJprotein A were purchased from 
Amersham International plc. Recombinant human M-CSF was ob- 
tained from Morinaga Milk Industry Co. (Tokyo, Japan). pSM c-fms 
containing the human c-fm cDNA and anti-c-fms polyclonal antibody 
were kindly provided by Charles J. Sherr. The human c-fmr cDNA was 
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inserted into a plasmid derived from the DNA provirus of the Susan 
McDonough strain of feline sarcoma virus (SM-FeSV) [12]. All rea- 
gents were of analytical grade. 
2.2. Cells and lipoproteins 
CHO-K cells were maintained in HAM containing 10% NCS in a 
humidified 5% CO2 incubator at 37°C. Mouse peritoneal macrophages 
were prepared according to the method of Cohn and Morse [13], and 
human monccytederived macrophages were cultured as described [14]. 
After 4 days of intraperitoneal injection of 1 ml of 2.5% thioglycolate 
medium I (Wake Pure Chemical Industries Ltd., Japan), peritoneal 
macrophages were harvested from C57BL6/J male mice in phosphate- 
buffered saline (PBS) containing 40 U/ml heparin. The cells were cul- 
tured with serum-free RPM1 medium on 12-well plastic dishes at a fhml 
concentration of 2 x IO6 cells/well and the cells were used 24 h after 
seeding. 
LDL was prepared from human plasma containing 0.1% EDTA, 
0.02% sodium azide and 0.5 mg/ml benzamidine at a density of 1.019- 
1.063 g/d1 by sequential ultracentrifugation [15]. The lipoprotein-defi- 
cient serum (LPDS) was also isolated at a density >1.21. LDL was 
acetylated by repeated additions of acetic anhydride as described [I. 
LDL and acetyl-LDL were radioiodinated with Na’251 using the iodine 
monochloride method [16]. 
2.3. Transfection of human c-fms cDNA 
The human c-fm cDNA (3.0 kb) was isolated after digestion with 
BamHl from pSMc-fms, a pBR325-based plasmid containing the 
human c-fms cDNA [12]. The c-fins cDNA fragment was inserted into 
the BamHI site of the pBluescript II vector with a ligase, and then 
excised with Hind111 and XbaI. Finally the c-fins cDNA was ligated 
orthodronomically into the HindIII-XbaI site of the Rc/CMV vector. 
Rc/CMV vector containing human c-fms cDNA was transfected into 
CHO-K cells by the calcium phosphate precipitation method using a 
transfection kit (CellPhect; Pharmacia LKB Biotechnology Inc). After 
2 days of transfection, the cells were subcultured on a 100~mm dish in 
10 ml HAM containing 10% NCS and 600 &ml G 418. After 3 weeks 
of culture with G418, G418-resistant clones were individually subcul- 
tuned and screened for c-fms expression by Northern blot analysis as 
described below. 
2.4. Northern blotting and Western blotting 
RNA was isolated from cells by the acid guanidium thiocyanatel 
phenol/chloroform (AGPC) method. Total RNA (20 pg) was analyzed 
by gel-electrophoresis of 1% agarose, 2.2 M formaldehyde gels and 
transferred to nitrocellulose filters. The filter was hybridized with c-fm 
probe labeled with [a-32P]dCTP by the random primer DNA labeling 
kit (Boehringer Mannheim Biochemica). 
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Cells were dissolved in 100 ~1 of lysis buffer containing 10 mM 
sodium phosphate, 100 mM NaCl, 1% T&on X-100,0.1% SDS, 0.5% 
deoxycholate, and 1 mM PMSF, at pH 7.5. The protein (100 pg) was 
subjected to 7% SDS-PAGE. After electrophoresis, the proteins were 
transferred to a nitrocellulose membrane. Thereafter, the nitrocellulose 
membrane was incubated with anti-c-fms polyclonal antibody and then 
incubated with [‘211]protein A. 
2.5. Degradation of lipoproteins 
The cells were cultured for, 3 days on 12-well plates in 1 ml HAM 
containing 10% NCS and 50 &ml M-CSF. After incubation for 36 h 
in medium containing 5 mg/ml LPDS and 50 r&ml M-CSF, cells were 
incubated for 12 h in medium in the presence or absence of 10 &ml 
LDL. lo&ml [‘251]lipoproteins were then added to the culture medium 
and incubated for a further 4 h. Degradation of [‘*‘I]lipoproteins was 
measured according to the method of Goldstein et al. [7,16]. 
2.6. Quantitative analysis of LDL receptor mRNA 
The competitive PCR method was adopted to measure mRNA levels 
[1;11. After incubation for 36 h on 10 cm dishes in 10 ml HAM contain- 
ing 5 mg/ml LPDS, cells were incubated for 48 h in medium containing 
LPDS. 1 pg of total RNA isolated from the cells was reverse-tran- 
scribed with random hexamer primers (Boehrlnger Mannheim Bio- 
chemica). The DNA fragment of the Chinese hamster LDL receptor 
gene (356 bp) was preparatively amplified from genomlc DNA of CHO 
cells with a pair of primers (primer A, 5’-TCGCCTCACAGGCTCA- 
GATG; primer B, S-TTGGCCAGTAGCATGCCATC) and used in 
the competitive PCR assay as a control template. Aliquots of the cDNA 
products and the control DNA were co-ampliied in a series of ratios 
as indicated using the same set of primers (primer A and B). The final 
products were run on a 1.5% agarose gel, followed by ethidium bromide 
staining. 
3. Results 
3.1. Transfection and expression of human c-fms gene into CHO 
cells 
The highest expression clone was designated CHO-fms. CHO 
Fig. 1. Northern blot analysis of human c-fins gene-transfected CHO 
cells. Cellular RNA was isolated by the acid guauidlum thiocyanatej 
phenol/chloroform method from CHO cells (wild-type CHO-K), CHO 
cells transfected with the ofms gene (CHO-fms), CHO cells trausfected 
with the empty vector (CHO(-)) as a negative control, and human 
monocyte-derived macrophages as a positive control. Total RNA 
(20 pg) was subjected to 1% formaldehyde gel-electrophoresis and 
transferred to nitrocelhtlose filters. The filter was hybridized with the 
human c-fmr cDNA probe. 
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Fig. 2. Immuuoblot analysis of human c-fmr gene transfected CHO 
cells. Total cell protein (100 ,ug) was extracted from the cells as 
described in Fig. 1 in lysis buffer and analyzed by 7% SDS-PAGE. 
Thereafter, proteins were transferred to nitrocellulose membrane. The 
nitrocellulose membrane was incubated with antic-fm polyclonal anti- 
body and then with [“‘I]protein A. 
cells transfected with the vector without c-fms cDNA were 
designated CHO(-) and used as control cells. In Northern blot 
analysis with a full-length c-fmr cDNA probe, human c-fms 
mRNA of the same size (3.2 kbp) as in human macrophages 
was detected in CHO-fms (Fig. 1). Human c-fms protein was 
demonstrated in these cells as a 160 kDa protein by im- 
munoblot analysis (Fig. 2), conlirming the expression of the 
introduced gene. 
3.2. Degradation of lipoproteins in CHO-fms cells 
LDL degradation activity was analyzed in CHO(-) and 
CHO-fms (Fig. 3). The cells were incubated for 48 h in medium 
containing LPDS to increase the LDL receptors. Degradation 
of LDL was significantly less (30%) in CHO-fms than in 
CHO(-). To analyze the effect of c-fms expression on LDL 
receptor activity more precisely, we calculated the sterol-sensi- 
tive portion of LDL receptor activity as the difference between 
LDL degradation in the assay in the presence or absence of 
LDL. LDL degradation in the presence of 10 &ml LDL was 
designated as the sterol-insensitive portion of LDL receptor 
activity (Fig. 3). Sterol-insensitive activity was not significantly 
different between the two cell types, whereas the sterol-sensitive 
activity was significantly lower in CHO-fm than in CHO(-). 
This indicates that introduction of the c-fms gene suppressed 
Table 1 
Degradation (ng/mg cell protein) of LDL and acetyl-LDL in CHO-fms 
and CHO(-) 
LDL acetyl-LDL 
CHO(-) 2649 f 748* 38 
CHO-fms 1846 + 668 19 
Mouse macrophages Not done 10,570 
Cells were incubated with 10 &ml LDL or ac-etyl-LDL for 4 h. Data 
represent mean ?r S.D. of 4 experiments or mean of two experiments. 
Each experiment was performed in triplicate. *P < 0.001, as compared 
to CHO-fis. 
74 
LDL receptor activity by reducing the sterol-sensitive portion 
of LDL receptor activity. These results were similar both in the 
presence and absence of M-CSF in the medium. 
Furthermore, acetyl-LDL degradation activity was exam- 
ined to study the effect of c-fms expression on scavenger recep- 
tor activity in CHO cells (Table 1). We found no increase in 
acetyl-LDL degradation activity in CHO-fms as compared to 
CHO(-). The data indicate that the introduction of the c-fms 
gene did not induce acetyl-LDL receptor activity in CHO cells, 
although CHO(-) had low scavenger eceptor activity. LDL 
and acetyl-LDL degradations were further evaluated in another 
CHO cell line which was transfected with c-fm, and the results 
were reproducible. 
3.3. Quantitative analysis of LDL mRNA on c-fms 
overexpressing CHO cells 
To determine whether suppression of LDL receptor activity 
by c-fms gene introduction was at the transcriptional evel, we 
estimated the mRNA level of LDL receptor in CHO(-) and 
CHO-fms using a competitive PCR method (Fig. 4). RT-PCR 
with the two specific primers produced the 222 bp targeted 
sequence of the LDL receptor derived from mRNA and the 356 
bp fragment derived from genomic DNA. During the PCR 
reaction containing both LDL receptor cDNA and genomic 
DNA, the two fragments were competitively amplified in a 
concentration-dependent manner. In this method, the relative 
concentrations of mRNA from both cell lines were calculated 
from the relative concentration of the cDNA to authentic 
genomic DNA. It was estimated that the amount of LDL recep- 
tor mRNA in CHO-fms was approximately 25% of that of 
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Fig. 3. LDL degradation activity in human c-fms transfected CHO cells. 
The cells were incubated for 3 days in HAM containing 10% NCS in 
the presence (black columns) or absence (open columns) of 50 ng/ml 
M-CSF. After incubation for 36 h in HAM containing 5 mg/ml LPDS 
in the presence or absence of 50 @ml M-CSF, cells were incubated for 
12 h in the medium in the presence (Sterol Insensitive) or absence of 
10 &ml LDL. 10 &ml [‘?lLDL was added to the cells and the cells 
were incubated for 4 h, and cell-degraded [‘?]LDL was measured. The 
sterol-sensitive portion was determined as the difference between the 
degradation activities in the presence and absence of 10 &ml LDL. 
100% indicates [‘ZSI]LDL degradation of control CHO cells in the ab- 
sence of both M-CSF and LDL, i.e. 2.65 crglmg cell protein. Data 
represent mean+S.E.M. of four experiments. *P < 0.05, **P < 0.001 
compared with degradation values of control cells, CHO(-). 
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Fig. 4. Quantitative amtlysis of LDL receptor mRNA in human c-fms- 
transfected CHO cells. After incubation for 48 h in HAM contaipino ----P 
5 mg/ml LPDS, total RNA of the cells was isolated. A portion of total 
RNA (2.8 ,ug) was subjected to reverse-transcription with random hex- 
amer primers. The control DNA template of the Chinese hamster LDL 
receptor gene (356 bp) was prepared from PCR with genomic DNA. 
cDNA products and the control DNA were mixed in a series of ratios 
as indicated and co-amplified by PCR, yielding a 222 bp fragment 
derived from LDL receptor mRNA as well as the control fragment 
(356 bp). The relative amount of the two products relfects the original 
content of LDL receptor mRNA and control template DNA. 
CHO(-). The data indicate that expression of LDL receptor is 
decreased in CHO-fms at the transcriptional evel. 
4. Discussion 
In the current study, we found that introduction of the c-fms 
gene into CHO cells decreased LDL receptor activity. It has 
been reported that differentiation of macrophage progenitors 
such as the HL-60 cells, a human promyelocytic leukemic cell 
line, and THP-1, a human acute monocytic leukemia cell line, 
into macrophages by phorbol esters is associated with induc- 
tion of c-fms gene and decreased LDL receptors [9,11,18]. Our 
results suggest hat induction of c-fms gene expression in mac- 
rophages primarily causes uppression of LDL receptor expres- 
sion and that the two events are not coincidental during differ- 
entiation. Suppression occurred at the transcriptional evel and 
affected the sterol-sensitive regulation of the LDL receptor. 
Introduction of the c-fms gene might affect the activity of the 
sterol-regulatory element in the promotor region of the LDL 
receptor gene. Interestingly, this effect was observed irrespec- 
tive of M-CSF treatment. This suggests that expression of c-fms 
itself might be important for suppression of the LDL receptor, 
or that the presence of minimal levels of M-CSF activity in the 
medium is sufficient to produce this effect. 
Differentiation of monocytes into macrophages i  accompa- 
nied by induction of the c-fms gene and scavenger activities 
[9,11,18], suggesting that scavenger eceptor expression is also 
related to c-fms expression. However, in the current study, we 
could not demonstrate induction of scavenger eceptor activity 
after transfection of c-fms gene into CHO cells, suggesting that 
c-fms expression is not related to scavenger eceptor activity. 
On the other hand, we found a low activity of scavenger recep- 
tor in CHO cells. It is possible that gene transfection of c-fms 
may not influence scavenger eceptor activity because of the 
substantial absence of receptors in CHO cells. CHO cells may 
lack some intracellular mediators in the cascade of M-CSF 
signal transduction to the expression of scavenger receptors, or 
other signals may be required for induction of scavenger activ- 
ity. 
In the present study, we found that introduction of the c-fms 
gene affects the expression of LDL receptors, one of the most 
important lipoprotein receptors regulating plasma and intracel- 
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lular cholesterol metabolism. This may explain why macro- 
phages have relatively low LDL receptor activity as compared 
to fibroblasts and hepatocytes which lack c-fms expression. The 
latter cells have strict regulatory systems for homeostasis of 
intracellular cholesterol content, including sterol-responsive 
regulation of LDL receptors, HMG-CoA reductase and syn- 
thetase, and acyl-CoA acyltransferase [19]. In contrast, macro- 
phages take up modified LDL without this type of regulation, 
forming foam cells. We previously reported the formation of 
foamy cells from CHO cells over-expressing LDL receptors 
after incubation with LDL. This indicates that when LDL re- 
ceptors are expressed without sterol regulation, native LDL 
could also produce foamy cells and might be involved in the 
development of early phases of atherosclerosis as well as mod- 
iiied LDL [ZO]. However, decreased expression of LDL recep- 
tors with c-fmr expression in macrophages uggests that native 
LDL contributes much less to early phases of atherogenesis 
than modified LDL or apoE-rich lipoproteins such as 
remnants. Since CHO cells are widely used in investigations, 
CHO-fms will be a valuable tool to study the relationship be- 
tween M-CSF receptors and lipoprotein metabolism or athero- 
sclerosis. 
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